References

Bernal JL, Andrews N, Gower C Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021; 385:585-594 https://doi.org/10.1056/NEJMoa210889
Bloomberg Vaccine Tracker. 2021. http://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/ (accessed October 2021)
Griffin JB, Haddix M, Danza P SARS-CoV-2 infections and hospitalizations among persons aged ≥16 years, by vaccination status – Los Angeles County, California, May 1–July 25, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70:1170-1176 https://doi.org/10.15585/mmwr.mm7034e5
How dangerous is the Delta variant. 2021. https://asm.org/Articles/2021/July/How-Dangerous-is-the-Delta-Variant-B-1-617-2 (accessed October 2021)
WHO. Tracking SARS-CoV-2 variants. 2021. http://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ (accessed October 2021)
WHO. Vaccines and trust. How concerns arise and the role of communication in mitigating crises. 2017. http://www.euro.who.int/__data/assets/pdf_file/0004/329647/Vaccines-and-trust.PDF (accessed October 2021)
CDC. Principles of epidemiology in public practice. 2012. https://www.cdc.gov/csels/dsepd/ss1978/ (accessed October 2021)
Weinberg GA, Szilagyi PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis. 2010; 201:1607-1610 https://doi.org/10.1086/652404
Speiser DE, Bachmann MF. COVID-19: mechanisms of vaccination and immunity. Vaccines (Basel). 2020; 8 https://doi.org/10.3390/vaccines8030404
Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011; 53:68-75 https://doi.org/10.1093/cid/cir270
Samaranayake LP, Seneviratne CJ, Fakhruddin KS. Coronavirus disease 2019 (COVID-19) vaccines: a concise review. Oral Dis. 2021; https://doi.org/10.1111/odi.13916
Pozzetto B, Legros V, Djebali S Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature. 2021; https://doi.org/10.1038/s41586-021-04120-y
Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005; 18:21-25 https://doi.org/10.1080/08998280.2005.11928028
Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nat Med. 2021; 27:1338-1339 https://doi.org/10.1038/s41591-021-01459-7
Gostic KM, Bridge R, Brady S Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLoS Pathog. 2019; 15 https://doi.org/10.1371/journal.ppat.1008109
Xu W, Wong G, Hwang YY, Larbi A. The untwining of immunosenescence and aging. Semin Immunopathol. 2020; 42:559-572 https://doi.org/10.1007/s00281-020-00824-x
Wagner A, Weinberger B. Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives. Front Immunol. 2020; 11 https://doi.org/10.3389/fimmu.2020.00717
Australian Government Department of Health. ATAGI: ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised. 2021. http://www.health.gov.au/resources/publications/atagi-recommendations-on-the-use-of-a-third-primary-dose-of-covid-19-vaccine-in-individuals-who-are-severely-immunocompromised (accessed October 2021)
WHO. Ten threats to global health 2019. 2020. http://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed October 2021)
WHO. Coronavirus disease (COVID-19): herd immunity, lockdowns and COVID-19. 2020. http://www.who.int/news-room/q-a-detail/herd-immunity-lockdowns-and-covid-19 (accessed October 2021)
Herd immunity: How does it work?. 2016. http://www.ovg.ox.ac.uk/news/herd-immunity-how-does-it-work (accessed October 2021)
Peiris M, Leung GM. What can we expect from first-generation COVID-19 vaccines?. Lancet. 2020; 396:1467-1469 https://doi.org/10.1016/S0140-6736(20)31976-0

Current COVID-19 vaccine epidemiology and dentistry

From Volume 48, Issue 10, November 2021 | Pages 881-886

Authors

Lakshman Samaranayake

DSc, DDS, FRCPath, FHKCPath, FDS RCS(Edin), FRACDS, FDS RCPS

Professor Emeritus, and Immediate-past Dean, Faculty of Dentistry, University of Hong Kong

Articles by Lakshman Samaranayake

Email Lakshman Samaranayake

Abstract

The coronavirus disease 2019 (COVID-19) vaccine story is continuously unfolding. Since our previous COVID-19 commentaries, much new information has transpired on the subject, and here we revisit this topic, which has practical implications for all stakeholders in dentistry, as well as the public. This article, on current vaccine epidemiology, provides an account of why vaccines fail in general, and the particular concerns in relation to the new Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related ‘variants of concern’. Issues related to vaccine failure are fundamentally dichotomous in nature, appertaining either to the vaccine strain (type) per se, and/or the numerous endogenous factors of the vaccine recipient/vaccinee. Societal factors such as vaccine hesitancy and its impact on herd immunity appear to overarch the long-term goal of total or partial global suppression of SARS-CoV-2, and its eventual endemicity.

CPD/Clinical Relevance: To describe the reasons for the failure of currently administered COVID-19 vaccines, particularly in relation to the advent of the SARS-CoV-2 ‘variants of concern’, and discuss implications for clinical dental practice.

Article

The biggest vaccination campaign in human history is ongoing. The battle against coronavirus disease 2019 (COVID-19) is virtually halfway through, with an armamentarium of vaccines, antivirals and other drugs, and an array of societal preventive measures. These have led to a global decrease in the COVID-19 numbers with a few pockets of higher morbidity and mortality. COVID-19 vaccines continue to lower the risk for severe COVID-19 disease, hospitalization and death, even against the more virulent Delta variant.1 Efficacious deployment of COVID-19 vaccines has offered humanity quick access to its endemicity. Since the first vaccine was administered in December 2020 in the UK, some 3.9 billion people have at least had a single shot, and 2.9 billion are fully vaccinated worldwide (as of 23 October 2021).2 This, together with those who have survived the infection, implies that about half of all people worldwide are likely to be immune to the disease today. Dental care workers, as frontline health professionals, were the earliest recipients of the vaccine, and some, in certain jurisdictions, were actively involved in the administration of vaccines as well. It is now highly likely that the annual vaccination schedule for dental healthcare workers (DHCW) will incorporate a compulsory COVID-19 vaccine.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available